Andrew Saik - Sep 21, 2022 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC. (ICPT)

Role
EVP & Chief Financial Officer
Signature
/s/ Rocco Venezia, as attorney-in-fact
Stock symbol
ICPT
Transactions as of
Sep 21, 2022
Transactions value $
-$13,484
Form type
4
Date filed
9/23/2022, 04:02 PM
Previous filing
Jun 23, 2022
Next filing
Dec 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICPT Common Stock Tax liability -$13.5K -908 -1.54% $14.85 57.9K Sep 21, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.